Loading…

Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN

Sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. We propose an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2024-05, Vol.15 (1), p.288-300
Main Authors: Ma, Kevin C, Mena, Esther, Lindenberg, Liza, Lay, Nathan S, Eclarinal, Phillip, Citrin, Deborah E, Pinto, Peter A, Wood, Bradford J, Dahut, William L, Gulley, James L, Madan, Ravi A, Choyke, Peter L, Turkbey, Ismail Baris, Harmon, Stephanie A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2673-cab0cce04db9d6f305e758cbdfd95b1de0be613f41ea0cbd7b2a798f6fcb769d3
container_end_page 300
container_issue 1
container_start_page 288
container_title Oncotarget
container_volume 15
creator Ma, Kevin C
Mena, Esther
Lindenberg, Liza
Lay, Nathan S
Eclarinal, Phillip
Citrin, Deborah E
Pinto, Peter A
Wood, Bradford J
Dahut, William L
Gulley, James L
Madan, Ravi A
Choyke, Peter L
Turkbey, Ismail Baris
Harmon, Stephanie A
description Sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. We propose an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for low-dose CT scans. A deep learning algorithm based on 2D Pix-2-Pix generative adversarial network (GAN) architecture was developed from paired AC-PET and NAC-PET images. F-DCFPyL PSMA PET-CT studies from 302 prostate cancer patients, split into training, validation, and testing cohorts ( = 183, 60, 59, respectively). Models were trained with two normalization strategies: Standard Uptake Value (SUV)-based and SUV-Nyul-based. Scan-level performance was evaluated by normalized mean square error (NMSE), mean absolute error (MAE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Lesion-level analysis was performed in regions-of-interest prospectively from nuclear medicine physicians. SUV metrics were evaluated using intraclass correlation coefficient (ICC), repeatability coefficient (RC), and linear mixed-effects modeling. Median NMSE, MAE, SSIM, and PSNR were 13.26%, 3.59%, 0.891, and 26.82, respectively, in the independent test cohort. ICC for SUV and SUV were 0.88 and 0.89, which indicated a high correlation between original and AI-generated quantitative imaging markers. Lesion location, density (Hounsfield units), and lesion uptake were all shown to impact relative error in generated SUV metrics (all < 0.05). The Pix-2-Pix GAN model for generating AC-PET demonstrates SUV metrics that highly correlate with original images. AI-generated PET images show clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality.
doi_str_mv 10.18632/oncotarget.28583
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11075367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3051940802</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2673-cab0cce04db9d6f305e758cbdfd95b1de0be613f41ea0cbd7b2a798f6fcb769d3</originalsourceid><addsrcrecordid>eNpVUclOw0AMHSEQoMIHcEE5cgnMkmSSE6pKWaQClSgHTqNZnDIozZSZhO3rGZWy-WBbtp_95IfQAcHHpCwYPXGtdp30c-iOaZmXbAPtkiqrUprnbPNPvoP2Q3jC0fKMl7TaRjus5ITyjOyihzOAZdKA9K1t56mSAUzy-ugaSJUz78n07nqYTMezk9EskV0HbS8769pEO-9Br9K-s439iOhkat9SmkafXAxv9tBWLZsA--s4QPfn49noMp3cXlyNhpNU04KzVEuFtQacGVWZomY4B56XWpnaVLkiBrCCgrA6IyBxLHNFJa_Kuqi14kVl2ACdfu1d9moBRkPbedmIpbcL6d-Fk1b877T2UczdiyAE85xFDgN0tN7g3XMPoRMLGzQ0jWzB9UFETvGZuMQ0jpKvUe1dCB7qnzsEi5Us4lcWsZIlYg7_EvxBfIvAPgExt41C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051940802</pqid></control><display><type>article</type><title>Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN</title><source>PubMed (Medline)</source><creator>Ma, Kevin C ; Mena, Esther ; Lindenberg, Liza ; Lay, Nathan S ; Eclarinal, Phillip ; Citrin, Deborah E ; Pinto, Peter A ; Wood, Bradford J ; Dahut, William L ; Gulley, James L ; Madan, Ravi A ; Choyke, Peter L ; Turkbey, Ismail Baris ; Harmon, Stephanie A</creator><creatorcontrib>Ma, Kevin C ; Mena, Esther ; Lindenberg, Liza ; Lay, Nathan S ; Eclarinal, Phillip ; Citrin, Deborah E ; Pinto, Peter A ; Wood, Bradford J ; Dahut, William L ; Gulley, James L ; Madan, Ravi A ; Choyke, Peter L ; Turkbey, Ismail Baris ; Harmon, Stephanie A</creatorcontrib><description>Sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. We propose an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for low-dose CT scans. A deep learning algorithm based on 2D Pix-2-Pix generative adversarial network (GAN) architecture was developed from paired AC-PET and NAC-PET images. F-DCFPyL PSMA PET-CT studies from 302 prostate cancer patients, split into training, validation, and testing cohorts ( = 183, 60, 59, respectively). Models were trained with two normalization strategies: Standard Uptake Value (SUV)-based and SUV-Nyul-based. Scan-level performance was evaluated by normalized mean square error (NMSE), mean absolute error (MAE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Lesion-level analysis was performed in regions-of-interest prospectively from nuclear medicine physicians. SUV metrics were evaluated using intraclass correlation coefficient (ICC), repeatability coefficient (RC), and linear mixed-effects modeling. Median NMSE, MAE, SSIM, and PSNR were 13.26%, 3.59%, 0.891, and 26.82, respectively, in the independent test cohort. ICC for SUV and SUV were 0.88 and 0.89, which indicated a high correlation between original and AI-generated quantitative imaging markers. Lesion location, density (Hounsfield units), and lesion uptake were all shown to impact relative error in generated SUV metrics (all &lt; 0.05). The Pix-2-Pix GAN model for generating AC-PET demonstrates SUV metrics that highly correlate with original images. AI-generated PET images show clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.28583</identifier><identifier>PMID: 38712741</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Aged ; Algorithms ; Antigens, Surface - metabolism ; Deep Learning ; Glutamate Carboxypeptidase II - metabolism ; Humans ; Image Processing, Computer-Assisted - methods ; Male ; Middle Aged ; Positron Emission Tomography Computed Tomography - methods ; Prostatic Neoplasms - diagnostic imaging ; Prostatic Neoplasms - pathology ; Radiopharmaceuticals ; Reproducibility of Results ; Research Paper</subject><ispartof>Oncotarget, 2024-05, Vol.15 (1), p.288-300</ispartof><rights>Copyright: © 2024 Ma et al.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2673-cab0cce04db9d6f305e758cbdfd95b1de0be613f41ea0cbd7b2a798f6fcb769d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075367/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075367/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38712741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Kevin C</creatorcontrib><creatorcontrib>Mena, Esther</creatorcontrib><creatorcontrib>Lindenberg, Liza</creatorcontrib><creatorcontrib>Lay, Nathan S</creatorcontrib><creatorcontrib>Eclarinal, Phillip</creatorcontrib><creatorcontrib>Citrin, Deborah E</creatorcontrib><creatorcontrib>Pinto, Peter A</creatorcontrib><creatorcontrib>Wood, Bradford J</creatorcontrib><creatorcontrib>Dahut, William L</creatorcontrib><creatorcontrib>Gulley, James L</creatorcontrib><creatorcontrib>Madan, Ravi A</creatorcontrib><creatorcontrib>Choyke, Peter L</creatorcontrib><creatorcontrib>Turkbey, Ismail Baris</creatorcontrib><creatorcontrib>Harmon, Stephanie A</creatorcontrib><title>Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. We propose an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for low-dose CT scans. A deep learning algorithm based on 2D Pix-2-Pix generative adversarial network (GAN) architecture was developed from paired AC-PET and NAC-PET images. F-DCFPyL PSMA PET-CT studies from 302 prostate cancer patients, split into training, validation, and testing cohorts ( = 183, 60, 59, respectively). Models were trained with two normalization strategies: Standard Uptake Value (SUV)-based and SUV-Nyul-based. Scan-level performance was evaluated by normalized mean square error (NMSE), mean absolute error (MAE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Lesion-level analysis was performed in regions-of-interest prospectively from nuclear medicine physicians. SUV metrics were evaluated using intraclass correlation coefficient (ICC), repeatability coefficient (RC), and linear mixed-effects modeling. Median NMSE, MAE, SSIM, and PSNR were 13.26%, 3.59%, 0.891, and 26.82, respectively, in the independent test cohort. ICC for SUV and SUV were 0.88 and 0.89, which indicated a high correlation between original and AI-generated quantitative imaging markers. Lesion location, density (Hounsfield units), and lesion uptake were all shown to impact relative error in generated SUV metrics (all &lt; 0.05). The Pix-2-Pix GAN model for generating AC-PET demonstrates SUV metrics that highly correlate with original images. AI-generated PET images show clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality.</description><subject>Aged</subject><subject>Algorithms</subject><subject>Antigens, Surface - metabolism</subject><subject>Deep Learning</subject><subject>Glutamate Carboxypeptidase II - metabolism</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted - methods</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Prostatic Neoplasms - diagnostic imaging</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Radiopharmaceuticals</subject><subject>Reproducibility of Results</subject><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVUclOw0AMHSEQoMIHcEE5cgnMkmSSE6pKWaQClSgHTqNZnDIozZSZhO3rGZWy-WBbtp_95IfQAcHHpCwYPXGtdp30c-iOaZmXbAPtkiqrUprnbPNPvoP2Q3jC0fKMl7TaRjus5ITyjOyihzOAZdKA9K1t56mSAUzy-ugaSJUz78n07nqYTMezk9EskV0HbS8769pEO-9Br9K-s439iOhkat9SmkafXAxv9tBWLZsA--s4QPfn49noMp3cXlyNhpNU04KzVEuFtQacGVWZomY4B56XWpnaVLkiBrCCgrA6IyBxLHNFJa_Kuqi14kVl2ACdfu1d9moBRkPbedmIpbcL6d-Fk1b877T2UczdiyAE85xFDgN0tN7g3XMPoRMLGzQ0jWzB9UFETvGZuMQ0jpKvUe1dCB7qnzsEi5Us4lcWsZIlYg7_EvxBfIvAPgExt41C</recordid><startdate>20240507</startdate><enddate>20240507</enddate><creator>Ma, Kevin C</creator><creator>Mena, Esther</creator><creator>Lindenberg, Liza</creator><creator>Lay, Nathan S</creator><creator>Eclarinal, Phillip</creator><creator>Citrin, Deborah E</creator><creator>Pinto, Peter A</creator><creator>Wood, Bradford J</creator><creator>Dahut, William L</creator><creator>Gulley, James L</creator><creator>Madan, Ravi A</creator><creator>Choyke, Peter L</creator><creator>Turkbey, Ismail Baris</creator><creator>Harmon, Stephanie A</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240507</creationdate><title>Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN</title><author>Ma, Kevin C ; Mena, Esther ; Lindenberg, Liza ; Lay, Nathan S ; Eclarinal, Phillip ; Citrin, Deborah E ; Pinto, Peter A ; Wood, Bradford J ; Dahut, William L ; Gulley, James L ; Madan, Ravi A ; Choyke, Peter L ; Turkbey, Ismail Baris ; Harmon, Stephanie A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2673-cab0cce04db9d6f305e758cbdfd95b1de0be613f41ea0cbd7b2a798f6fcb769d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Algorithms</topic><topic>Antigens, Surface - metabolism</topic><topic>Deep Learning</topic><topic>Glutamate Carboxypeptidase II - metabolism</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted - methods</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Prostatic Neoplasms - diagnostic imaging</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Radiopharmaceuticals</topic><topic>Reproducibility of Results</topic><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Ma, Kevin C</creatorcontrib><creatorcontrib>Mena, Esther</creatorcontrib><creatorcontrib>Lindenberg, Liza</creatorcontrib><creatorcontrib>Lay, Nathan S</creatorcontrib><creatorcontrib>Eclarinal, Phillip</creatorcontrib><creatorcontrib>Citrin, Deborah E</creatorcontrib><creatorcontrib>Pinto, Peter A</creatorcontrib><creatorcontrib>Wood, Bradford J</creatorcontrib><creatorcontrib>Dahut, William L</creatorcontrib><creatorcontrib>Gulley, James L</creatorcontrib><creatorcontrib>Madan, Ravi A</creatorcontrib><creatorcontrib>Choyke, Peter L</creatorcontrib><creatorcontrib>Turkbey, Ismail Baris</creatorcontrib><creatorcontrib>Harmon, Stephanie A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Kevin C</au><au>Mena, Esther</au><au>Lindenberg, Liza</au><au>Lay, Nathan S</au><au>Eclarinal, Phillip</au><au>Citrin, Deborah E</au><au>Pinto, Peter A</au><au>Wood, Bradford J</au><au>Dahut, William L</au><au>Gulley, James L</au><au>Madan, Ravi A</au><au>Choyke, Peter L</au><au>Turkbey, Ismail Baris</au><au>Harmon, Stephanie A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2024-05-07</date><risdate>2024</risdate><volume>15</volume><issue>1</issue><spage>288</spage><epage>300</epage><pages>288-300</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. We propose an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for low-dose CT scans. A deep learning algorithm based on 2D Pix-2-Pix generative adversarial network (GAN) architecture was developed from paired AC-PET and NAC-PET images. F-DCFPyL PSMA PET-CT studies from 302 prostate cancer patients, split into training, validation, and testing cohorts ( = 183, 60, 59, respectively). Models were trained with two normalization strategies: Standard Uptake Value (SUV)-based and SUV-Nyul-based. Scan-level performance was evaluated by normalized mean square error (NMSE), mean absolute error (MAE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Lesion-level analysis was performed in regions-of-interest prospectively from nuclear medicine physicians. SUV metrics were evaluated using intraclass correlation coefficient (ICC), repeatability coefficient (RC), and linear mixed-effects modeling. Median NMSE, MAE, SSIM, and PSNR were 13.26%, 3.59%, 0.891, and 26.82, respectively, in the independent test cohort. ICC for SUV and SUV were 0.88 and 0.89, which indicated a high correlation between original and AI-generated quantitative imaging markers. Lesion location, density (Hounsfield units), and lesion uptake were all shown to impact relative error in generated SUV metrics (all &lt; 0.05). The Pix-2-Pix GAN model for generating AC-PET demonstrates SUV metrics that highly correlate with original images. AI-generated PET images show clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>38712741</pmid><doi>10.18632/oncotarget.28583</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2024-05, Vol.15 (1), p.288-300
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11075367
source PubMed (Medline)
subjects Aged
Algorithms
Antigens, Surface - metabolism
Deep Learning
Glutamate Carboxypeptidase II - metabolism
Humans
Image Processing, Computer-Assisted - methods
Male
Middle Aged
Positron Emission Tomography Computed Tomography - methods
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Radiopharmaceuticals
Reproducibility of Results
Research Paper
title Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A02%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deep%20learning-based%20whole-body%20PSMA%20PET/CT%20attenuation%20correction%20utilizing%20Pix-2-Pix%20GAN&rft.jtitle=Oncotarget&rft.au=Ma,%20Kevin%20C&rft.date=2024-05-07&rft.volume=15&rft.issue=1&rft.spage=288&rft.epage=300&rft.pages=288-300&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.28583&rft_dat=%3Cproquest_pubme%3E3051940802%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2673-cab0cce04db9d6f305e758cbdfd95b1de0be613f41ea0cbd7b2a798f6fcb769d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3051940802&rft_id=info:pmid/38712741&rfr_iscdi=true